Close Menu

NEW YORK — Israeli proteomics firm OncoHost said today that it and its partner RayBiotech have received a $1 million grant from the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation.

The fund will support the companies' development and clinical validation of a test to predict patient response to immunotherapy treatment in non-small cell lung cancer and to develop an automated slide assistance platform to enable large-scale protein processing for host response enrichment work for pharmaceutical companies.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.